Ratings by Nephron (Eric Percher)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Elevance | ELV | New Coverage | Hold (N/A) |
323.05 (373.11) |
15.5% | Details | |
| 4/20/2026 | Oscar Health Inc | OSCR | New Coverage | Buy (N/A) |
15.79 (29.10) |
84.29% | Details | |
| 4/20/2026 | UnitedHealth Group | UNH | New Coverage | Buy (N/A) |
324.63 (426.09) |
31.25% | Details | |
| 4/20/2026 | Molina Healthcare | MOH | New Coverage | Buy (N/A) |
148.97 (225.37) |
51.29% | Details | |
| 4/20/2026 | CIGNA | CI | New Coverage | Hold (N/A) |
278.64 (281.45) |
1.01% | Details | |
| 4/20/2026 | CVS Health | CVS | New Coverage | Hold (N/A) |
77.30 (107.47) |
39.03% | Details | |
| 4/20/2026 | Centene | CNC | New Coverage | Buy (N/A) |
38.17 (66.44) |
74.06% | Details | |
| 3/9/2026 | Hims and Hers | HIMS | Upgrade | Buy (Hold) |
15.74 (32.84) |
108.64% | Details | |
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Hold (N/A) |
40.52 (39.79) |
-1.8% | Details | |
| 2/25/2025 | Hims and Hers | HIMS | Downgrade | Hold (Buy) |
51.31 (15.74) |
-69.32% | Details | |
| 12/3/2024 | Hims and Hers | HIMS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Hims and Hers | HIMS | New Coverage | Buy (N/A) |
21.73 (32.84) |
51.13% | Details | |
| 11/21/2022 | Walgreens Boosts Alliance | WBA | Upgrade | Hold (Sell) |
39.75 (11.98) |
-69.86% | Details |
